Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Meglizide M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Silicon Pharma

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Meglizide M 80mg/500mg Tablet

Glimepiride/Metformin 80mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue this treatment even with controlled blood sugar; discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medicine complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice) to mitigate hypoglycemia. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Meglizide M 80mg/500mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Meglizide M 80mg/500mg Tablet

Non-insulin-dependent diabetes

Major Benefits of Meglizide M 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Meglizide M 80mg/500mg Tablet should be taken with a meal.

Common Side effects of Meglizide M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Meglizide M 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meglizide M 80mg/500mg tablets should be administered with food.

How Meglizide M 80mg/500mg Tablet works:

Gliclazide and metformin, combined in Meglizide M 80mg/500mg tablets, offer a dual-action approach to diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Meglizide M 80mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Meglizide M 80mg/500mg tablets is contraindicated in pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Meglizide M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Meglizide M 80mg/500mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Meglizide M 80mg/500mg Tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Meglizide M 80mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Meglizide M 80mg/500mg Tablet :

Should you forget to take your Meglizide M 80mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Meglizide M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Meglizide M 80mg/500mg Tablet

Meglizide M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Meglizide M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Meglizide M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Meglizide M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Meglizide M 80mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Patients allergic to Meglizide M 80mg/500mg Tablet components or excipients, or those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining Meglizide M 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Meglizide M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Meglizide M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Meglizide M 80mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Meglizide M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Prolonged use of Meglizide M 80mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Meglizide M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Meglizide M 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Meglizide M 80mg/500mg Ta...
50
MRP 58
13% off